These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23433950)

  • 1. Investigation of outcomes following recombinant activated FVII use for refractory bleeding during abdominal aortic aneurysm repair.
    Kandane-Rathnayake RK; Willis CD; Beiles CB; Bourke BM; Cameron PA; McCall P; Phillips LE
    Eur J Vasc Endovasc Surg; 2013 Jun; 45(6):617-25. PubMed ID: 23433950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Končar IB; Davidović LB; Savić N; Sinđelić RB; Ilić N; Dragas M; Markovic M; Kostic D
    J Vasc Surg; 2011 Apr; 53(4):1032-7. PubMed ID: 21215579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invited commentary.
    Hoch JR
    J Vasc Surg; 2011 Apr; 53(4):1037-8. PubMed ID: 21439457
    [No Abstract]   [Full Text] [Related]  

  • 4. Life expectancy and causes of death after repair of intact and ruptured abdominal aortic aneurysms.
    Bastos Gonçalves F; Ultee KH; Hoeks SE; Stolker RJ; Verhagen HJ
    J Vasc Surg; 2016 Mar; 63(3):610-6. PubMed ID: 26553951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of hemodynamic status on outcomes of endovascular abdominal aortic aneurysm repair for rupture.
    Mehta M; Paty PS; Byrne J; Roddy SP; Taggert JB; Sternbach Y; Ozsvath KJ; Darling RC
    J Vasc Surg; 2013 May; 57(5):1255-60. PubMed ID: 23388393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic scoring in ruptured abdominal aortic aneurysm: a prospective evaluation.
    Tambyraja AL; Lee AJ; Murie JA; Chalmers RT
    J Vasc Surg; 2008 Feb; 47(2):282-6. PubMed ID: 18241750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register.
    Isbister J; Phillips L; Dunkley S; Jankelowitz G; McNeil J; Cameron P
    Intern Med J; 2008 Mar; 38(3):156-65. PubMed ID: 17916172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iatrogenic Major Venous Injury Is Associated with Increased Morbidity of Aortic Reconstruction.
    Hans SS; Vang S; Sachwani-Daswani G
    Ann Vasc Surg; 2018 Feb; 47():200-204. PubMed ID: 28887236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding.
    Kandane-Rathnayake RK; Isbister JP; Zatta AJ; Aoki NJ; Cameron P; Phillips LE;
    ANZ J Surg; 2013 Mar; 83(3):155-60. PubMed ID: 23035873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved trends in patient survival and decreased major complications after emergency ruptured abdominal aortic aneurysm repair.
    Brahmbhatt R; Gander J; Duwayri Y; Rajani RR; Veeraswamy R; Salam A; Dodson TF; Arya S
    J Vasc Surg; 2016 Jan; 63(1):39-47. PubMed ID: 26506941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measure what matters: institutional outcome data are superior to the use of surrogate markers to define "center of excellence" for abdominal aortic aneurysm repair.
    Goshima KR; Mills JL; Awari K; Pike SL; Hughes JD
    Ann Vasc Surg; 2008; 22(3):328-34. PubMed ID: 18411029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decade of change in abdominal aortic aneurysm repair in the United States: Have we improved outcomes equally between men and women?
    Dillavou ED; Muluk SC; Makaroun MS
    J Vasc Surg; 2006 Feb; 43(2):230-8; discussion 238. PubMed ID: 16476592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of recombinant activated factor VII in trauma patients: Experience from the Australian and New Zealand haemostasis registry.
    Cameron P; Phillips L; Balogh Z; Joseph A; Pearce A; Parr M; Jankelowitz G
    Injury; 2007 Sep; 38(9):1030-8. PubMed ID: 17706654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradigm shifts in the treatment of abdominal aortic aneurysm: trends in 721 patients between 1996 and 2008.
    Albuquerque FC; Tonnessen BH; Noll RE; Cires G; Kim JK; Sternbergh WC
    J Vasc Surg; 2010 Jun; 51(6):1348-52; discussion 1352-3. PubMed ID: 20488317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 30-day mortality of ruptured abdominal aortic aneurysms: influence of gender, age, diameter and comorbidities.
    Alexander S; Bosch JL; Hendriks JM; Visser JJ; Van Sambeek MR
    J Cardiovasc Surg (Torino); 2008 Oct; 49(5):633-7. PubMed ID: 18670381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age stratified, perioperative, and one-year mortality after abdominal aortic aneurysm repair: a statewide experience.
    Rigberg DA; Zingmond DS; McGory ML; Maggard MA; Agustin M; Lawrence PF; Ko CY
    J Vasc Surg; 2006 Feb; 43(2):224-9. PubMed ID: 16476591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of gender on long-term survival after abdominal aortic aneurysm repair based on results from the Medicare national database.
    Egorova NN; Vouyouka AG; McKinsey JF; Faries PL; Kent KC; Moskowitz AJ; Gelijns A
    J Vasc Surg; 2011 Jul; 54(1):1-12.e6; discussion 11-2. PubMed ID: 21498023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality variability after endovascular versus open abdominal aortic aneurysm repair in a large tertiary vascular center using a Medicare-derived risk prediction model.
    Hicks CW; Black JH; Arhuidese I; Asanova L; Qazi U; Perler BA; Freischlag JA; Malas MB
    J Vasc Surg; 2015 Feb; 61(2):291-7. PubMed ID: 25154686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of perioperative transfusion with 30-day morbidity and mortality in patients undergoing major vascular surgery.
    Obi AT; Park YJ; Bove P; Cuff R; Kazmers A; Gurm HS; Grossman PM; Henke PK
    J Vasc Surg; 2015 Apr; 61(4):1000-9.e1. PubMed ID: 25596978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.